Suppr超能文献

有机化学与生物学:合作视角下的化学生物学。

Organic chemistry and biology: chemical biology through the eyes of collaboration.

机构信息

Department of Chemistry and Biochemistry, The University of Arizona, Tucson, Arizona 85721, USA.

出版信息

J Org Chem. 2009 Dec 18;74(24):9245-64. doi: 10.1021/jo901767e.

Abstract

From a scientific perspective, efforts to understand biology including what constitutes health and disease has become a chemical problem. However, chemists and biologists "see" the problems of understanding biology from different perspectives, and this has retarded progress in solving the problems especially as they relate to health and disease. This suggests that close collaboration between chemists and biologists is not only necessary but essential for progress in both the biology and chemistry that will provide solutions to the global questions of biology. This perspective has directed my scientific efforts for the past 45 years, and in this overview I provide my perspective of how the applications of synthetic chemistry, structural design, and numerous other chemical principles have intersected in my collaborations with biologists to provide new tools, new science, and new insights that were only made possible and fruitful by these collaborations.

摘要

从科学的角度来看,理解生物学(包括健康和疾病的构成)的努力已经成为一个化学问题。然而,化学家与生物学家从不同的视角“看待”生物学问题,这阻碍了问题的解决进展,尤其是在与健康和疾病相关的问题方面。这表明,化学家与生物学家之间的密切合作不仅是必要的,而且对于生物学和化学的进展也是至关重要的,因为这将为生物学的全球性问题提供解决方案。这一观点指导了我过去 45 年的科学努力,在这篇综述中,我提供了自己的观点,即合成化学的应用、结构设计以及许多其他化学原理是如何在与生物学家的合作中交汇的,这些合作提供了新的工具、新的科学和新的见解,这些合作使这些新的工具、科学和见解成为可能并富有成效。

相似文献

1
Organic chemistry and biology: chemical biology through the eyes of collaboration.
J Org Chem. 2009 Dec 18;74(24):9245-64. doi: 10.1021/jo901767e.
2
Synthetic biology: history, challenges and prospects.
J R Soc Interface. 2009 Aug 6;6 Suppl 4(Suppl 4):S389-91. doi: 10.1098/rsif.2009.0176.focus. Epub 2009 Jun 3.
3
Synthetic biology: lessons from the history of synthetic organic chemistry.
Nat Chem Biol. 2007 Sep;3(9):521-5. doi: 10.1038/nchembio0907-521.
4
Enzyme immunoassays as screening tools for catalysts and reaction discovery.
Chem Commun (Camb). 2015 May 11;51(38):7996-8009. doi: 10.1039/c5cc00599j. Epub 2015 Mar 13.
6
[Organic synthesis].
C R Acad Sci III. 2000 May;323(5):441-5. doi: 10.1016/s0764-4469(00)00149-9.
7
Advances in acyl anion and homoenolate catalysis.
Curr Opin Drug Discov Devel. 2007 Nov;10(6):691-703.
8
Teaching target-oriented and diversity-oriented organic synthesis at Harvard University.
Chem Biol. 2002 May;9(5):535-41. doi: 10.1016/s1074-5521(02)00143-6.
9
Future trends in microwave synthesis.
Future Med Chem. 2010 Feb;2(2):151-5. doi: 10.4155/fmc.09.133.
10
Race for molecular summits.
Science. 1999 Jul 9;285(5425):184-5, 187. doi: 10.1126/science.285.5425.184.

引用本文的文献

1
Discovery of Novel Multifunctional Ligands with μ/δ Opioid Agonist/Neurokinin-1 (NK1) Antagonist Activities for the Treatment of Pain.
J Med Chem. 2015 Nov 12;58(21):8573-83. doi: 10.1021/acs.jmedchem.5b01170. Epub 2015 Oct 30.
2
Discovery of tripeptide-derived multifunctional ligands possessing delta/mu opioid receptor agonist and neurokinin 1 receptor antagonist activities.
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3716-20. doi: 10.1016/j.bmcl.2015.06.030. Epub 2015 Jun 15.
3
Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain.
Expert Opin Investig Drugs. 2014 Feb;23(2):227-41. doi: 10.1517/13543784.2014.856879. Epub 2013 Dec 13.
5
Design of peptide and peptidomimetic ligands with novel pharmacological activity profiles.
Annu Rev Pharmacol Toxicol. 2013;53:557-80. doi: 10.1146/annurev-pharmtox-010510-100456.
6
Natural products as sources of new drugs over the 30 years from 1981 to 2010.
J Nat Prod. 2012 Mar 23;75(3):311-35. doi: 10.1021/np200906s. Epub 2012 Feb 8.
10
Design of novel melanocortin receptor ligands: multiple receptors, complex pharmacology, the challenge.
Eur J Pharmacol. 2011 Jun 11;660(1):88-93. doi: 10.1016/j.ejphar.2010.10.109. Epub 2011 Jan 3.

本文引用的文献

1
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors.
Angew Chem Int Ed Engl. 1998 Nov 2;37(20):2754-2794. doi: 10.1002/(SICI)1521-3773(19981102)37:20<2754::AID-ANIE2754>3.0.CO;2-3.
3
Solid-Phase Synthesis of Heterobivalent Ligands Targeted to Melanocortin and Cholecystokinin Receptors.
Int J Pept Res Ther. 2008 Dec;14(4):293-300. doi: 10.1007/s10989-008-9150-3.
7
Effects of selective modulation of the central melanocortin-3-receptor on food intake and hypothalamic POMC expression.
Peptides. 2008 Mar;29(3):440-7. doi: 10.1016/j.peptides.2007.11.005. Epub 2007 Nov 21.
8
Asymmetric Eschenmoser-Claisen rearrangement for anti-beta-substituted gamma,delta-unsaturated amino acids.
Org Lett. 2007 Sep 27;9(20):3997-4000. doi: 10.1021/ol701704h. Epub 2007 Aug 31.
9
Melanocortin-4 receptor agonists for the treatment of obesity.
Curr Top Med Chem. 2007;7(11):1121-30. doi: 10.2174/156802607780906636.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验